COVERSYL Side Effects

6386875-8 | Acute Respiratory Failure, Hyperkalaemia, Prostatic Disorder, Renal Failure Acute
on Sep 18, 2009 Male patient from FRANCE , 80 years of age, was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, hyperkalaemia, prostatic disorder, renal failure acute. Coversyl dosage: . Patient was hospitalized.

6347692-8 | Asthenia, Gait Disturbance, Hypersensitivity, Muscle Spasms, Myalgia, Swollen Tongue
Patient was taking Coversyl (View Usage). Patient had the following side effects: asthenia, gait disturbance, hypersensitivity, muscle spasms, myalgia, swollen tongue on Aug 31, 2009 from CANADA Additional patient health information: Female patient , 67 years of age, weighting 163.1 lb, . Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6022670-7 | Anxiety, Chest Discomfort, Depression, Fatigue, Impaired Work Ability, Insomnia, Tinnitus, Visual Impairment
Adverse event was reported on Dec 16, 2008 by a Female patient taking Coversyl (View Usage) (Dosage: Daily Dose: 8 Milligram(s)) was diagnosed with hypertension and. Location: CANADA , 47 years of age, After Coversyl was administered, patient had the following side effects: anxiety (What is anxiety?), chest discomfort, depression (What is depression?), fatigue, impaired work ability, insomnia, tinnitus (What is tinnitus?), visual impairment.

5942099-7 | Condition Aggravated, Dermatitis Exfoliative, Psoriasis, Pyrexia
on Oct 28, 2008 Male patient from FRANCE , 54 years of age, was diagnosed with myocardial infarction and was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, dermatitis exfoliative, psoriasis, pyrexia. Coversyl dosage: . During the same period patient was treated with PLAVIX (Unk) (View Plavix Review and Plavix Label ), HYDROCORTISONE (8 Mg) (View Hydrocortisone Review and Hydrocortisone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), KINERET (Unk) (View Kineret Review and Kineret Label ), TEMERIT (Unk) (View Temerit Review and Temerit Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.


5923282-3 | Anxiety, Balance Disorder, Cerebral Cyst, Confusional State, Epilepsy, Incoherent, Memory Impairment
on Oct 08, 2008 Male patient from CANADA , 50 years of age, was diagnosed with hypertension and was treated with Coversyl (View Usage). Patient had the following side effects: anxiety (What is anxiety?), balance disorder, cerebral cyst, confusional state, epilepsy (What is epilepsy?), incoherent, memory impairment. Coversyl dosage: Daily Dose: 8 Milligram(s).

5908649-1 | Atrial Fibrillation, Diarrhoea, Hyperkalaemia, Nausea, Renal Failure, Renal Failure Chronic
Patient was taking Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), diarrhoea, hyperkalaemia, nausea (What is nausea?), renal failure, renal failure chronic on Sep 26, 2008 from FRANCE Additional patient health information: Female patient , 75 years of age, . Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), POTASSIUM GLUCONATE TAB (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), XANAX (View Xanax Review and Xanax Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5874743-7 | Urticaria
Adverse event was reported on Aug 27, 2008 by a Male patient taking Coversyl (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with hypertension, localised infection and. Location: CANADA , 74 years of age, Patient experienced the following unwanted or unexpected effects: urticaria. During the same period patient was treated with KEFLEX (View Keflex Review and Keflex Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), TETRACYCLINE (View Tetracycline Review and Tetracycline Label ).

5806834-0 | Epilepsy, Fall, Ill-defined Disorder, Walking Disability
on Jun 30, 2008 Male patient from FRANCE , 81 years of age, was diagnosed with hypertension, epilepsy (What is epilepsy?), prostatic adenoma, prophylaxis, hypercholesterolaemia and was treated with Coversyl (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?), fall (What is fall?), ill-defined disorder, walking disability. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with DEPAKENE (Daily Dose: 1000 Milligram(s)) (View Depakene Review and Depakene Label ), PROSCAR (Daily Dose: 5 Milligram(s)) (View Proscar Review and Proscar Label ), SKELID (Daily Dose: 400 Milligram(s)) (View Skelid Review and Skelid Label ), KARDEGIC (Daily Dose: 75 Milligram(s)) (View Kardegic Review and Kardegic Label ), TAHOR (Daily Dose: 80 Milligram(s)) (View Tahor Review and Tahor Label ). Patient was hospitalized.

5706884-9 | Toxic Skin Eruption
on Apr 03, 2008 Female patient from BELGIUM , weighting 132.3 lb, was diagnosed with hypertension and was treated with Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: toxic skin eruption. Coversyl dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

5654640-2 | Anxiety, Balance Disorder, Confusional State, Incoherent, Memory Impairment
Patient was taking Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), balance disorder, confusional state, incoherent, memory impairment on Feb 28, 2008 from CANADA Additional patient health information: Male patient , 50 years of age, was diagnosed with hypertension and. Coversyl dosage: Daily Dose: 8 Milligram(s).

5605903-8 | Abnormal Behaviour, Conjunctival Hyperaemia, Convulsion, Eczema, Hallucination
Adverse event was reported on Jan 15, 2008 by a Female patient taking Coversyl (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with hypertension and. Location: FRANCE , 81 years of age, Patient had the following side effects: abnormal behaviour, conjunctival hyperaemia, convulsion, eczema (What is eczema?), hallucination. During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ). Patient was hospitalized.

5571508-0 | Acidosis, Anaphylactoid Reaction, Cardiac Arrest, Renal Failure, Septic Shock
on Nov 21, 2007 Female patient from UNITED KINGDOM , 66 years of age, was diagnosed with hypertension and was treated with Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: acidosis, anaphylactoid reaction, cardiac arrest (What is cardiac arrest?), renal failure, septic shock. Coversyl dosage: . Patient was hospitalized.

5568215-7 | Dizziness, Loss Of Consciousness
on Dec 06, 2007 Female patient from ITALY , 65 years of age, was diagnosed with hypertension and was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), loss of consciousness. Coversyl dosage: Daily Dose: 4 Milligram(s).

5554824-8 | Angioedema, Dysphagia, Dyspnoea, Prostate Cancer, Scrotal Oedema
Patient was taking Coversyl (View Usage). Patient had the following side effects: angioedema, dysphagia, dyspnoea, prostate cancer (What is prostate cancer?), scrotal oedema on Nov 30, 2007 from FRANCE Additional patient health information: Male patient , 79 years of age, was diagnosed with hypertension, ill-defined disorder and. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with DECAPEPTYL (View Decapeptyl Review and Decapeptyl Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), OLMETEC (Daily Dose: 40 Milligram(s)) (View Olmetec Review and Olmetec Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

5537007-7 | Eczema
Adverse event was reported on Nov 30, 2007 by a Male patient taking Coversyl (View Usage) (Dosage: ) was diagnosed with ill-defined disorder and. Location: FRANCE , 46 years of age, After Coversyl was administered, patient had the following side effects: eczema (What is eczema?). During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), BEFIZAL (View Befizal Review and Befizal Label ), TAREG (View Tareg Review and Tareg Label ). Patient was hospitalized.

5528785-1 | Acidosis, Anaphylactoid Reaction, Cardiac Arrest, Renal Failure, Septic Shock
on Nov 19, 2007 Female patient from UNITED KINGDOM , 66 years of age, was diagnosed with ill-defined disorder and was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, anaphylactoid reaction, cardiac arrest (What is cardiac arrest?), renal failure, septic shock. Coversyl dosage: . Patient was hospitalized.

5521708-0 | Angina Pectoris
on Nov 12, 2007 Male patient from NETHERLANDS , 80 years of age, was diagnosed with hypertension and was treated with Coversyl (View Usage). Patient had the following side effects: angina pectoris. Coversyl dosage: Daily Dose: 4 Milligram(s). Patient was hospitalized.

5520584-X | Hypokalaemia, Hypotension, Intentional Overdose, Metabolic Acidosis, Renal Failure, Urinary Retention
Patient was taking Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: hypokalaemia, hypotension, intentional overdose, metabolic acidosis, renal failure, urinary retention on Nov 13, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 43 years of age, was diagnosed with ill-defined disorder and. Coversyl dosage: Daily Dose: 120 Milligram(s). During the same period patient was treated with AMLODIPINE (Daily Dose: 560 Milligram(s)) (View Amlodipine Review and Amlodipine Label ), FLUOXETINE (Daily Dose: 600 Milligram(s)) (View Fluoxetine Review and Fluoxetine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ACETYLSALICYLIC ACID SRT (Daily Dose: 7.5 Gram(s)) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PARACETAMOL (Daily Dose: 16 Gram(s)) (View Paracetamol Review and Paracetamol Label ), CITALOPRAM (Daily Dose: 280 Milligram(s)) (View Citalopram Review and Citalopram Label ). Patient was hospitalized.

5448636-3 | Osteonecrosis
Adverse event was reported on Aug 31, 2007 by a Female patient taking Coversyl (View Usage) (Dosage: Daily Dose: 2 Milligram(s)) was diagnosed with hypertension, ill-defined disorder, osteoporosis (What is osteoporosis?), hypothyroidism, peripheral arterial occlusive disease and. Location: FRANCE , 75 years of age, Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). During the same period patient was treated with CALCIDOSE (View Calcidose Review and Calcidose Label ), ZOMETA (Daily Dose: 4 Milligram(s)) (View Zometa Review and Zometa Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), KREDEX (Daily Dose: 12.5 Milligram(s)) (View Kredex Review and Kredex Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), AROMASIN (Daily Dose: 25 Milligram(s)) (View Aromasin Review and Aromasin Label ), LEVOTHYROX (Daily Dose: 100 Microgram(s)) (View Levothyrox Review and Levothyrox Label ), PLAVIX (Daily Dose: 75 Milligram(s)) (View Plavix Review and Plavix Label ).

5445956-3 | Haemodynamic Instability, Hyperkalaemia, Lung Disorder, Multi-organ Failure, Orthopnoea, Pleural Effusion, Pneumonitis, Renal Failure Acute
on Aug 28, 2007 Male patient from FRANCE , 79 years of age, was diagnosed with ill-defined disorder and was treated with Coversyl (View Usage). Patient had the following side effects: haemodynamic instability, hyperkalaemia, lung disorder, multi-organ failure, orthopnoea, pleural effusion, pneumonitis, renal failure acute. Coversyl dosage: Daily Dose: 2 Milligram(s). During the same period patient was treated with AMIODARONE (Daily Dose: 200 Milligram(s), 5 A Week) (View Amiodarone Review and Amiodarone Label ), DIGOXIN (Daily Dose: .25 Milligram(s)) (View Digoxin Review and Digoxin Label ), PLAVIX (Daily Dose: 75 Milligram(s)) (View Plavix Review and Plavix Label ). Patient was hospitalized.

5419731-X | Cough, Disorientation, Dyspnoea, Wheezing
on Aug 01, 2007 Female patient from NETHERLANDS , 48 years of age, was diagnosed with ill-defined disorder and was treated with Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: cough, disorientation, dyspnoea, wheezing. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), ASCAL CARDIO (View Ascal Cardio Review and Ascal Cardio Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ).

5405386-7 | Acidosis, Diarrhoea, Hypotension, Oliguria, Oral Intake Reduced, Renal Failure Acute
Patient was taking Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, diarrhoea, hypotension, oliguria, oral intake reduced, renal failure acute on Jan 04, 2007 from AUSTRALIA Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with essential hypertension, cardiac failure congestive and. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with FRUSEMIDE (Daily Dose: 40 Milligram(s)) (View Frusemide Review and Frusemide Label ). Patient was hospitalized.

5080490-4 | Atrial Fibrillation, Disease Recurrence, Dyspnoea Exertional, Pulmonary Oedema
Adverse event was reported on Mar 26, 1999 by a Male patient taking Coversyl (View Usage) (Dosage: ) was diagnosed with cardiac failure congestive, ill-defined disorder and. Location: FRANCE , 73 years of age, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), disease recurrence, dyspnoea exertional, pulmonary oedema. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), PREVISCAN (View Previscan Review and Previscan Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), CORDARONE (View Cordarone Review and Cordarone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5080465-5 | Cerebral Haemorrhage, Coma
on Mar 31, 1999 Male patient from FRANCE , 60 years of age, was diagnosed with hypertension and was treated with Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: cerebral haemorrhage, coma. Coversyl dosage: .

5080435-7 | Quadriplegia
on Jun 13, 2001 Male patient from FRANCE , 73 years of age, weighting 202.8 lb, was diagnosed with cardiac failure congestive and was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: quadriplegia. Coversyl dosage: Daily Dose: 4 Mg.. Patient was hospitalized.

5080430-8 | Angina Pectoris, Cerebrovascular Accident, Ischaemic Stroke, Left Ventricular Failure
Patient was taking Coversyl (View Usage). Patient had the following side effects: angina pectoris, cerebrovascular accident, ischaemic stroke, left ventricular failure on Oct 21, 1999 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with cardiac failure congestive, ill-defined disorder and. Coversyl dosage: Daily Dose: Unk.. During the same period patient was treated with SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), TRIVASTAL RETARD (View Trivastal Retard Review and Trivastal Retard Label ), IKOREL (View Ikorel Review and Ikorel Label ), SECTRAL (View Sectral Review and Sectral Label ). Patient was hospitalized.

5080415-1 | Chest Pain, Coronary Artery Disease
Adverse event was reported on Sep 16, 1998 by a Male patient taking Coversyl (View Usage) (Dosage: Daily Dose: 2 Mg.) was diagnosed with cardiac failure congestive, ill-defined disorder and. Location: FRANCE , 67 years of age, After Coversyl was administered, patient had the following side effects: chest pain (What is chest pain?), coronary artery disease (What is coronary artery disease?). During the same period patient was treated with ISOPTIN (View Isoptin Review and Isoptin Label ), ALDALIX (View Aldalix Review and Aldalix Label ), SOLUPSAN (View Solupsan Review and Solupsan Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SERESTA (View Seresta Review and Seresta Label ). Patient was hospitalized.

5080414-X | Myeloproliferative Disorder
on May 23, 2001 Male patient from FRANCE , 71 years of age, weighting 169.8 lb, was diagnosed with cardiac failure congestive and was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: myeloproliferative disorder. Coversyl dosage: Daily Dose: Unk.. Patient was hospitalized.

5067425-5 | Fall, Orthostatic Hypotension
on Jun 30, 2006 Female patient from FRANCE , 80 years of age, was diagnosed with ill-defined disorder and was treated with Coversyl (View Usage). Patient had the following side effects: fall (What is fall?), orthostatic hypotension. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with PHYSIOTENS (Daily Dose: 1 Dosage Form) (View Physiotens Review and Physiotens Label ), ALDACTAZINE (Daily Dose: 1 Dosage Form) (View Aldactazine Review and Aldactazine Label ), EUPRESSYL (Daily Dose: 2 Dosage Form) (View Eupressyl Review and Eupressyl Label ). Patient was hospitalized.

5059544-4 | Confusional State, Hyponatraemia
Patient was taking Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: confusional state, hyponatraemia on Jul 07, 2006 from FRANCE Additional patient health information: Female patient , 87 years of age, was diagnosed with hypertension and. Coversyl dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (80 Mg/day) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PLAVIX (View Plavix Review and Plavix Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), TANAKAN (View Tanakan Review and Tanakan Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), TAREG (80 Mg, Qd) (View Tareg Review and Tareg Label ). Patient was hospitalized.

5055991-5 | Cardiac Arrest, Circulatory Collapse, Ejection Fraction Decreased, Haemodialysis, Hyperkalaemia, Loss Of Consciousness, Lung Disorder
Adverse event was reported on Jul 11, 2006 by a Male patient taking Coversyl (View Usage) (Dosage: Daily Dose: 1 Dosage Form) was diagnosed with ill-defined disorder and. Location: FRANCE , 78 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), circulatory collapse, ejection fraction decreased, haemodialysis, hyperkalaemia, loss of consciousness, lung disorder. During the same period patient was treated with ADANCOR (View Adancor Review and Adancor Label ), ALDACTONE (Daily Dose: 25 Milligram(s)) (View Aldactone Review and Aldactone Label ), TAHOR (View Tahor Review and Tahor Label ), LASILIX (Daily Dose: 80 Milligram(s)) (View Lasilix Review and Lasilix Label ), DISCOTRINE (View Discotrine Review and Discotrine Label ).

5055838-7 | Cytolytic Hepatitis
on Jul 12, 2006 Male patient from FRANCE , weighting 198.4 lb, was diagnosed with hypertension and was treated with Coversyl (View Usage). Patient had the following side effects: cytolytic hepatitis. Coversyl dosage: Daily Dose: 4 Milligram(s). Patient was hospitalized.

5051229-3 | Confusional State, Hyponatraemia
on Jul 07, 2006 Female patient from FRANCE , 87 years of age, was diagnosed with hypertension and was treated with Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: confusional state, hyponatraemia. Coversyl dosage: . During the same period patient was treated with TAHOR (80 Mg/day) (View Tahor Review and Tahor Label ), PLAVIX (View Plavix Review and Plavix Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), TANAKAN (View Tanakan Review and Tanakan Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), TAREG (80 Mg, Qd) (View Tareg Review and Tareg Label ). Patient was hospitalized.

5045739-2 | Fall, Orthostatic Hypotension
Patient was taking Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), orthostatic hypotension on Jun 30, 2006 from FRANCE Additional patient health information: Female patient , 80 years of age, was diagnosed with ill-defined disorder and. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with ALDACTAZIDE (View Aldactazide Review and Aldactazide Label ), PHYSIOTENS (Daily Dose: 1 Dosage Form) (View Physiotens Review and Physiotens Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ). Patient was hospitalized.

5029481-X | Angina Unstable, Bladder Cancer, Hyperkalaemia, Normochromic Normocytic Anaemia, Renal Failure Acute, Sepsis
Adverse event was reported on Jun 07, 2006 by a Male patient taking Coversyl (View Usage) (Dosage: Daily Dose: 2 Milligram(s)) was diagnosed with ill-defined disorder and. Location: FRANCE , 77 years of age, Patient had the following side effects: angina unstable, bladder cancer (What is bladder cancer?), hyperkalaemia, normochromic normocytic anaemia, renal failure acute, sepsis (What is sepsis?). During the same period patient was treated with TARDYFERON (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

5027617-8 | Apraxia, Cerebral Haematoma, Cerebrovascular Accident, Extensor Plantar Response, Fall, Hypertension, Sensorimotor Disorder, Speech Disorder
on Jun 07, 2006 Female patient from FRANCE , 84 years of age, weighting 132.3 lb, was treated with Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: apraxia, cerebral haematoma, cerebrovascular accident, extensor plantar response, fall (What is fall?), hypertension, sensorimotor disorder, speech disorder. Coversyl dosage: 4 Mg, Qd. During the same period patient was treated with VEINAMITOL (1 Df, Qd) (View Veinamitol Review and Veinamitol Label ), FOSAMAX (1 Df, Qw) (View Fosamax Review and Fosamax Label ), PREVISCAN (0.5 Df, Qd) (View Previscan Review and Previscan Label ), DEROXAT (20 Mg, Qd) (View Deroxat Review and Deroxat Label ), PRAVASTATIN (40 Mg, Qd) (View Pravastatin Review and Pravastatin Label ), HYPERIUM (1 Df, Qd) (View Hyperium Review and Hyperium Label ), FORLAX (1 To 2 Tabs/day) (View Forlax Review and Forlax Label ), IXPRIM (4 Df, Qd) (View Ixprim Review and Ixprim Label ). Patient was hospitalized.

5015784-1 | Angina Unstable
on May 22, 2006 Male patient from JAPAN , weighting 129.0 lb, was diagnosed with hypertension, ill-defined disorder and was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: angina unstable. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PANALDINE (View Panaldine Review and Panaldine Label ), MELBIN (View Melbin Review and Melbin Label ), AMARYL (View Amaryl Review and Amaryl Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).

5015773-7 | Atrioventricular Block Complete, Hyperkalaemia
Patient was taking Coversyl (View Usage). Patient had the following side effects: atrioventricular block complete, hyperkalaemia on Apr 18, 2006 from MALAYSIA Additional patient health information: Male patient , 59 years of age, was diagnosed with hypertension, ill-defined disorder and. Coversyl dosage: Daily Dose: 2 Milligram(s). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PRAZOSIN HCL (View Prazosin Hcl Review and Prazosin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), NEUROBION (View Neurobion Review and Neurobion Label ), INSULIN (View Insulin Review and Insulin Label ), NATRILIX SR (View Natrilix Sr Review and Natrilix Sr Label ). Patient was hospitalized.

5012103-1 | Mitral Valve Disease, Thrombocytopenia
Adverse event was reported on May 17, 2006 by a Male patient taking Coversyl (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with ill-defined disorder and. Location: FRANCE , 69 years of age, After Coversyl was administered, patient had the following side effects: mitral valve disease, thrombocytopenia. During the same period patient was treated with ALDACTONE (Daily Dose: 25 Milligram(s)) (View Aldactone Review and Aldactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PARIET (Daily Dose: 20 Milligram(s)) (View Pariet Review and Pariet Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

5007967-1 | Acidosis, Electrocardiogram Change, Hyperkalaemia
on Mar 28, 2006 Male patient from UNITED KINGDOM , weighting 147.7 lb, was diagnosed with hypertension, ill-defined disorder, prophylaxis and was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, electrocardiogram change, hyperkalaemia. Coversyl dosage: Daily Dose: 8 Milligram(s). During the same period patient was treated with DIAMICRON MR (Daily Dose: 30 Milligram(s)) (View Diamicron Mr Review and Diamicron Mr Label ), FUROSIDE (View Furoside Review and Furoside Label ), AMILORIDE (Daily Dose: 5 Milligram(s)) (View Amiloride Review and Amiloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METFORMIN (View Metformin Review and Metformin Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ). Patient was hospitalized.

5002715-3 | Dyspnoea, Pulmonary Oedema, Tachycardia, Urinary Retention
on May 03, 2006 Male patient from IRELAND , 66 years of age, was diagnosed with cardiac failure, ill-defined disorder and was treated with Coversyl (View Usage). Patient had the following side effects: dyspnoea, pulmonary oedema, tachycardia, urinary retention. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with XATRAL (View Xatral Review and Xatral Label ), LASIX (View Lasix Review and Lasix Label ), NIOPAM (View Niopam Review and Niopam Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CORDARONE (View Cordarone Review and Cordarone Label ), IMDUR (View Imdur Review and Imdur Label ), LOSEC (View Losec Review and Losec Label ), NU SEALS (View Nu-seals Review and Nu-seals Label ). Patient was hospitalized.

4980216-6 | Asthenia, Cyanosis, Dehydration, Gait Disturbance, Hyperkalaemia, Hypothermia
Patient was taking Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: asthenia, cyanosis, dehydration, gait disturbance, hyperkalaemia, hypothermia (What is hypothermia?) on Apr 10, 2006 from FRANCE Additional patient health information: Female patient , 79 years of age, weighting 158.7 lb, was diagnosed with cardiac failure, ill-defined disorder, lymphoedema and. Coversyl dosage: Daily Dose: 2 Milligram(s). During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASILIX (Daily Dose: 80 Milligram(s)) (View Lasilix Review and Lasilix Label ), DIFFU K (Daily Dose: 3 Dosage Form) (View Diffu K Review and Diffu K Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

4974925-2 | Acidosis, Electrocardiogram Change, Hyperkalaemia
Adverse event was reported on Mar 28, 2006 by a Male patient taking Coversyl (View Usage) (Dosage: Daily Dose: 8 Milligram(s)) was diagnosed with hypertension, ill-defined disorder, prophylaxis and. Location: UNITED KINGDOM , weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: acidosis, electrocardiogram change, hyperkalaemia. During the same period patient was treated with DIAMICRON MR (Daily Dose: 30 Milligram(s)) (View Diamicron Mr Review and Diamicron Mr Label ), FUROSIDE (View Furoside Review and Furoside Label ), AMILORIDE HYDROCHLORIDE (Daily Dose: 5 Milligram(s)) (View Amiloride Hydrochloride Review and Amiloride Hydrochloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METFORMIN (View Metformin Review and Metformin Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ). Patient was hospitalized.

4974924-0 | Hemiplegia, Subdural Haematoma
on Apr 05, 2006 Male patient from JAPAN , weighting 99.21 lb, was diagnosed with hypertension, ill-defined disorder and was treated with Coversyl (View Usage). Patient had the following side effects: hemiplegia, subdural haematoma. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with PLETAL (View Pletal Review and Pletal Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), NICERGOLINE (View Nicergoline Review and Nicergoline Label ), AMARYL (View Amaryl Review and Amaryl Label ).

4962850-2 | Arrhythmia, Bradyarrhythmia, Glycosylated Haemoglobin Increased, Hyperhidrosis, Hyperkalaemia, Ketoacidosis, Loss Of Consciousness, Malaise
on Mar 30, 2006 Female patient from FRANCE , 64 years of age, weighting 220.5 lb, was diagnosed with ill-defined disorder and was treated with Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), bradyarrhythmia, glycosylated haemoglobin increased, hyperhidrosis, hyperkalaemia, ketoacidosis, loss of consciousness, malaise. Coversyl dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), ACTOS (View Actos Review and Actos Label ), DAONIL (View Daonil Review and Daonil Label ). Patient was hospitalized.

4954040-4 | Atrioventricular Block First Degree, Coma, Overdose, Respiratory Distress
Patient was taking Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block first degree, coma, overdose, respiratory distress on Mar 14, 2006 from FRANCE Additional patient health information: Female patient , 85 years of age, weighting 165.3 lb, was diagnosed with ill-defined disorder and. Coversyl dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), HYTACAND (View Hytacand Review and Hytacand Label ), BENZODIAZEPINE (View Benzodiazepine Review and Benzodiazepine Label ). Patient was hospitalized.

4953731-9 | Acute Respiratory Failure, Crepitations, Dyspnoea, Lung Infection, Pulmonary Fibrosis, Respiratory Distress
Adverse event was reported on Sep 12, 2005 by a Male patient taking Coversyl (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with ill-defined disorder, arrhythmia (What is arrhythmia?) and. Location: FRANCE , 80 years of age, weighting 160.9 lb, Patient had the following side effects: acute respiratory failure, crepitations, dyspnoea, lung infection, pulmonary fibrosis (What is pulmonary fibrosis?), respiratory distress. During the same period patient was treated with FLECAINIDE ACETATE (Daily Dose: 250 Milligram(s)) (View Flecainide Acetate Review and Flecainide Acetate Label ), PLAVIX (Daily Dose: 75 Milligram(s)) (View Plavix Review and Plavix Label ), ZOCOR (Daily Dose: 40 Milligram(s)) (View Zocor Review and Zocor Label ), TENORMIN (Daily Dose: 100 Milligram(s)) (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

4945268-8 | Agranulocytosis, Coronary Angioplasty, Inflammation, Myocardial Infarction
on Feb 23, 2006 Male patient from UNITED STATES , 59 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Coversyl (View Usage). After Coversyl was administered, patient had the following side effects: agranulocytosis, coronary angioplasty, inflammation, myocardial infarction. Coversyl dosage: 4 Mg/day. During the same period patient was treated with OMEPRAZOLE (20 Mg/day) (View Omeprazole Review and Omeprazole Label ), PLAVIX (75 Mg/day) (View Plavix Review and Plavix Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TAHOR (View Tahor Review and Tahor Label ), SOPROL (View Soprol Review and Soprol Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TRIATEC (View Triatec Review and Triatec Label ). Patient was hospitalized.

4937166-0 | Blood Potassium Increased, Hypercalcaemia
on Feb 28, 2006 Female patient from UNITED KINGDOM , 71 years of age, was diagnosed with ill-defined disorder and was treated with Coversyl (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, hypercalcaemia. Coversyl dosage: Daily Dose: 2 Milligram(s). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ). Patient was hospitalized.

4930325-2 | Alveolitis, Interstitial Lung Disease, Left Ventricular Failure, Pulmonary Embolism, Pulmonary Fibrosis, Pulmonary Hypertension
Patient was taking Coversyl (View Usage). Patient had the following side effects: alveolitis, interstitial lung disease, left ventricular failure, pulmonary embolism (What is pulmonary embolism?), pulmonary fibrosis (What is pulmonary fibrosis?), pulmonary hypertension (What is pulmonary hypertension?) on Feb 22, 2006 from FRANCE Additional patient health information: Female patient , weighting 164.5 lb, was diagnosed with ill-defined disorder and. Coversyl dosage: . During the same period patient was treated with PROZAC (Daily Dose: 40 Milligram(s)) (View Prozac Review and Prozac Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ), DITROPAN (View Ditropan Review and Ditropan Label ), IMOVANE (View Imovane Review and Imovane Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized and became disabled.